tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ACST is currently covered by 1 analysts with an average price target of $31.27. This is a potential upside of $27.9 (827.89%) from yesterday's end of day stock price of $3.37.
Acasti Pharma's activity chart (see below) currently has 3 price targets and 6 ratings on display. The stock rating distribution of ACST is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 48.33 days.
Highest price target for ACST is $4, Lowest price target is $4, average price target is $31.27.
Most recent stock forecast was given by CONSTANTINE DAVIDES from BENCHMARK on 15-Feb-2023. First documented stock forecast 13-Jan-2020.
Currently out of the existing stock ratings of ACST, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2.5
$-0.28 (-10.07%)
1 years 10 months 30 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy
$30
2 years 6 months 23 days ago
(22-Jun-2022)
0/1 (0%)
$22.32 (290.63%)
Buy
4 years 4 months 14 days ago
(31-Aug-2020)
0/1 (0%)
$59.52 (163.16%)
What is ACST (Acasti Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on ACST (Acasti Pharma) with a proven track record?
Which analyst has the current lower performing score on ACST (Acasti Pharma) with a proven track record?
Which analyst has the most public recommendations on ACST (Acasti Pharma)?
Which analyst is the currently most bullish on ACST (Acasti Pharma)?
Which analyst is the currently most reserved on ACST (Acasti Pharma)?
